Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review: Stiolto Respimat Emerges as a Potential Drug
Triggered by prolonged exposure to hazardous gases such as cigarette smoke and factory emissions, chronic obstructive pulmonary disease (COPD) is a chronic lung disease, characterized by breathlessness. COPD exhibits substantial occurrences across the globe, however complete cure is yet to be attained owing to under developed therapeutics. Several pharmaceutical companies as well as research institutes are thus engaged in apt therapeutics development for enhanced COPD management. This recent business intelligence report titled, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review,...
View full press release